Tezepelumab Efficacy and Safety in Reducing Oral Corticosteroid Use in Adults With Oral Corticosteroid Dependent Asthma
Clinical trial NCT05398263 · TERMINATED
Trial details
- NCT number
- NCT05398263
- Sponsor
- AstraZeneca
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-09
- Primary completion
- 2025-03-24
- Enrollment
- 125
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.